Diakonos Oncology Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A
- (Upcoming)
- Investors
-
4
Diakonos Oncology General Information
Description
Developer of a clinical-stage immunotherapy platform intended to focus on treating aggressive cancers. The company utilizes a proprietary double-loaded, patient-derived dendritic cell therapeutic technology to address unmet medical needs in late-stage oncology, enabling cancer treatment through targeted and personalized immune system activation.
Contact Information
Website
www.diakonosoncology.comCorporate Office
- Houston, TX 77058
- United States
Corporate Office
- Houston, TX 77058
- United States
Diakonos Oncology Timeline
Diakonos Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | Upcoming | Clinical Trials - Phase 2 | ||||
| 2. Early Stage VC | 30-May-2025 | Completed | Clinical Trials - Phase 2 | |||
| 1. Seed Round | 26-Aug-2024 | $11.4M | $11.4M | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Diakonos Oncology Signals
Diakonos Oncology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | ||
| Buttonwood Group Advisors | Asset Manager | |||
| The Brain Tumor Investment Fund | Not-For-Profit Venture Capital | |||
| RESTEM (Biotechnology) | Corporation | Minority |
Diakonos Oncology FAQs
-
When was Diakonos Oncology founded?
Diakonos Oncology was founded in 2022.
-
Where is Diakonos Oncology headquartered?
Diakonos Oncology is headquartered in Houston, TX.
-
What is the size of Diakonos Oncology?
Diakonos Oncology has 14 total employees.
-
What industry is Diakonos Oncology in?
Diakonos Oncology’s primary industry is Drug Discovery.
-
Is Diakonos Oncology a private or public company?
Diakonos Oncology is a Private company.
-
What is Diakonos Oncology’s current revenue?
The current revenue for Diakonos Oncology is .
-
How much funding has Diakonos Oncology raised over time?
Diakonos Oncology has raised $31.4M.
-
Who are Diakonos Oncology’s investors?
BCM Ventures, Buttonwood Group Advisors, The Brain Tumor Investment Fund, and RESTEM (Biotechnology) have invested in Diakonos Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process